A detailed history of Lummis Asset Management, LP transactions in Pfizer Inc stock. As of the latest transaction made, Lummis Asset Management, LP holds 11,314 shares of PFE stock, worth $274,930. This represents 0.19% of its overall portfolio holdings.

Number of Shares
11,314
Holding current value
$274,930
% of portfolio
0.19%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$25.01 - $27.13 $282,963 - $306,948
11,314 New
11,314 $276 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $295,634 - $383,997
11,314 New
11,314 $326 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $136B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lummis Asset Management, LP Portfolio

Follow Lummis Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lummis Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Lummis Asset Management, LP with notifications on news.